Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.90    0.00 (0.00%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €110.59b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
1st Apr 20255:26 pmRNSEarly redemption of Senior Preferred Notes
1st Apr 20255:19 pmRNSEarly redemption of Senior Preferred Notes
28th Mar 20257:25 amRNSAdjunstments on the tender offer to Banco Sabadell
21st Mar 20255:18 pmRNSPrudential Relevance Report - Pillar 3 2024
21st Mar 20254:39 pmRNSResult of AGM
11th Mar 20259:27 amRNSStabilisation Notice - BBVA
17th Feb 20253:27 pmRNSStabilisation Notice-BBVA
17th Feb 20257:56 amRNSStabilisation Notice- BBVA
14th Feb 20255:39 pmRNS2025 AGM Notice and Proposed Resolutions
14th Feb 20255:38 pmRNSApril dividend calendar
12th Feb 20257:00 amRNS2025 Annual General Meeting Call
30th Jan 20257:00 amRNSShareholder remuneration for 2024
30th Jan 20257:00 amRNS4Q24 Quarterly Report
30th Jan 20257:00 amRNS4Q24 Results Press Release
30th Jan 20257:00 amRNS4Q24 Earnings Presentation
28th Jan 20255:07 pmRNSRedemption of preferred securities
22nd Jan 202510:32 amRNSBBVA 4Q24 Quarterly Results
9th Jan 20255:48 pmRNSBBVA offer modification
8th Jan 20257:00 amRNSIssue of preferred securities
27th Dec 20247:00 amRNSForm-8.3 Smith (DS) plc - BBVA SA - Unwind 1
23rd Dec 20245:11 pmRNSForm-8.3 Smith (DS) plc - BBVA SA
11th Dec 20245:44 pmRNSBBVA Minimum Capital Requirements for 2025
4th Dec 20245:04 pmRNSEarly Redemption of Subordinated Notes issuance
12th Nov 20245:48 pmRNSCNMC's Resolution on Commencement of Second Phase
31st Oct 20247:00 amRNS3Q24 Results Press Release
31st Oct 20247:00 amRNS3Q24 Results Report
31st Oct 20247:00 amRNS3Q24 Results Presentation
23rd Oct 202411:15 amRNS3Q24 Earnings Presentation Announcement
1st Oct 20246:29 pmRNSAdjustments to the Offer consideration
26th Sep 20248:51 amRNSPost Stabilisation Notice - BBVA 12NC7 Tier 2
26th Sep 20247:04 amRNSIssue of securities contingently convertible
26th Sep 20247:00 amRNSDividend October 2024
5th Sep 20245:17 pmRNSECB Non-opposition to tender offer for B. Sabadell
3rd Sep 20247:26 amRNSAuthorization from the Prudential Regula Authority
31st Jul 20247:00 amRNS2Q24 Results Report
31st Jul 20247:00 amRNS2Q24 Results Press Release
31st Jul 20247:00 amRNS2Q24 Results Presentation
30th Jul 20245:34 pmRNSOrganizational changes
24th Jul 202410:25 amRNS2Q24 Results Presentation Announcement
5th Jul 202411:31 amRNSResolutions adopted at the 2024 Extraordinary AGM
4th Jun 20246:01 pmRNSIssue of preferred securities contingently conv
31st May 20247:00 amRNSBBVA’s Extraordinary General Meeting Call
24th May 20245:52 pmRNSRequest for authorisation voluntary takeover bid
24th May 20245:10 pmRNSBBVAs share capital reduction
9th May 20249:36 amRNSOffer to Banco Sabadell Shareholders Presentation
9th May 20249:33 amRNSPress release offer to Banco Sabadell shareholders
9th May 20249:27 amRNSOffer Announcement Presentation
9th May 20247:00 amRNSVolunt.Tender Offer acquisition shares B.Sabadell
1st May 202412:04 pmRNSLetter to the Board of Directors of Banco Sabadell
30th Apr 20241:37 pmRNSInterest in negotiations with Banco Sabadell

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.